Privi Speciality Chemicals Limited has informed the Exchange regarding outcome of Board meeting held on December 19, 2025. inter alia approved Scheme of Amalgamation
PRIVISCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Privi Speciality Chemicals Limited, at its meeting held on December 19, 2025, approved a Scheme of Amalgamation. The company has informed the stock exchanges about this outcome, as required under listing rules. The headline does not specify the counterparty entity, the share swap ratio, or the strategic rationale. This board approval is only the first step in the amalgamation process, which would subsequently require NCLT approval, shareholder and creditor consent, and other regulatory clearances before becoming effective.
No immediate impact on share price or shareholder action is expected at this stage, as the scheme still needs NCLT and regulatory approvals. Investors should look out for the detailed scheme document and share swap ratio once filed with the NCLT.